Applying artificial intelligence to the ECG may make it possible to screen patients with chronic kidney disease (CKD) for hyperkalemia without making them get a blood test, a study showed. Researchers ...
QRS interval widening appears to be highly specific for the diagnosis of hyperkalemia in patients with end-stage kidney disease. ECG changes, in general, have poor sensitivities for hyperkalemia in ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration ...
AliveCor has received approval from the Food and Drug Administration (FDA) to develop a non-invasive method of detecting high blood potassium levels. The startup, which chiefly focuses on monitoring ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA Breakthrough Device ...
In patients with severe hyperkalemia, the Brugada syndrome ECG phenotype is associated with a high prevalence of malignant arrhythmias and all-cause mortality. Among patients with severe hyperkalemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results